1SINGH M, CHAKRAPANI A, O'HAGAN D. Nanoparticles and microparticles as vaccine-delivery systems [ J ]. Expert Rev Vaccines ,2007,6(5 ) :797 - 808.
2KOHANE D S. Microparticles and nanoparticles for drug delivery[J]. Biotechnol Bioeng,2007, 96(2) :203 -209.
3MULLER R H, RUNGE S, RAVELLI V, et al. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals [ J ]. Int J Pharm, 2006, 317(1) :82 -89.
4YANG S,ZHU J,LU Y,et al. Preparation and characterization of camptothecin solid lipid nanoparticles [ J ]. Drug Dev Ind Pharm ,2002,28 ( 3 ) :265 - 274.
5ARAYA H,NAGAO S, TOMITA M, et al. The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion I: enhancing effects on oral bioavailability of poorly water soluble compounds in rats and beagle dogs [ J ]. Drug Metab Pharmacokinet ,2005, 20(4) :244 -56.
8JACOBS C, KAYSER O, MLLER R H. Production and characterization of mucoadhesive nanosuspensions for the formulation of bupravaquone 备[J]. Int J Pharm,2001,214( 1 - 2):3 -7.
